{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:20:40Z","timestamp":1780503640224,"version":"3.54.1"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81802540"],"award-info":[{"award-number":["No. 81802540"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["No. 20180550985"],"award-info":[{"award-number":["No. 20180550985"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2020.595657","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T09:24:45Z","timestamp":1605259485000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer"],"prefix":"10.3389","volume":"11","author":[{"given":"Enchong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer.","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/1176935119835522","article-title":"Transcriptomics signature from next-generation sequencing data reveals new transcriptomic biomarkers related to prostate cancer.","volume":"18","author":"Alkhateeb","year":"2019","journal-title":"Cancer Inform."},{"key":"B3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.celrep.2014.01.013","article-title":"Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants.","volume":"6","author":"An","year":"2014","journal-title":"Cell Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat. Genet."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2004-353","article-title":"To examine serum paraoxonase 1 and 3 activities in benign and malignant diseases of the prostate, and changes in levels following robotic-assisted laparoscopic radical prostatectomy.","author":"Bed\u0130r","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: disseminating data to the public for the future of immunology.","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol. Res."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.15","article-title":"ImmPort, toward repurposing of open access immunological assay data for translational and clinical research.","volume":"5","author":"Bhattacharya","year":"2018","journal-title":"Sci. Data"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1158\/1078-0432.CCR-17-0019","article-title":"Immunotherapy of prostate cancer: facts and hopes.","volume":"23","author":"Bilusic","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.059","article-title":"SnapShot: TCGA-analyzed tumors.","volume":"173","author":"Blum","year":"2018","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer.","volume":"163","year":"2015","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"B12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","article-title":"High-risk prostate cancer-classification and therapy.","volume":"11","author":"Chang","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.2147\/OTT.S164131","article-title":"MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS.","volume":"11","author":"Chang","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s12026-017-8931-1","article-title":"Dendritic cell-based immunotherapy: a basic review and recent advances.","volume":"65","author":"Constantino","year":"2017","journal-title":"Immunol. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.celrep.2018.02.058","article-title":"Bimodal CD40\/Fas-dependent crosstalk between iNKT cells and tumor-associated macrophages impairs prostate cancer progression.","volume":"22","author":"Cortesi","year":"2018","journal-title":"Cell Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2217\/epi-2019-0236","article-title":"Neuroendocrine prostate cancer: long noncoding RNAs to treat an incurable cancer - an interview with Dr Francesco Crea.","volume":"11","author":"Crea","year":"2019","journal-title":"Epigenomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nri2817","article-title":"Prostate cancer as a model for tumour immunotherapy.","volume":"10","author":"Drake","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-2776(06)90002-9","article-title":"Mechanisms of immune evasion by tumors.","volume":"90","author":"Drake","year":"2006","journal-title":"Adv. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1471-4159.2008.05624.x","article-title":"Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.","volume":"107","author":"Dubessy","year":"2008","journal-title":"J. Neurochem."},{"key":"B20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","article-title":"Myc-driven murine prostate cancer shares molecular features with human prostate tumors.","volume":"4","author":"Ellwood-Yen","year":"2003","journal-title":"Cancer Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2217\/epi-2017-0114","article-title":"The upregulation of hypoxia-related miRNA 210 in primary tumor of lymphogenic metastatic prostate cancer.","volume":"10","author":"Eminaga","year":"2018","journal-title":"Epigenomics"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-019-0730-1","article-title":"Statistical predictions with glmnet.","volume":"11","author":"Engebretsen","year":"2019","journal-title":"Clin. Epigenet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/pros.23742","article-title":"M2 macrophages and regulatory T cells in lethal prostate cancer.","volume":"79","author":"Erlandsson","year":"2019","journal-title":"Prostate"},{"key":"B24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2217\/epi-2018-0131","article-title":"Fine mapping and subphenotyping implicates ADRA1B gene variants in psoriasis susceptibility in a Chinese population.","volume":"11","author":"Fan","year":"2019","journal-title":"Epigenomics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8 cytotoxic T lymphocytes in cancer immunotherapy: a review.","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"B27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","article-title":"Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories.","volume":"34","author":"Gerhauser","year":"2018","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/cbf.3426","article-title":"IGSF1: a novel oncogene regulates the thyroid cancer progression.","volume":"37","author":"Guan","year":"2019","journal-title":"Cell Biochem. Funct."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9040219","article-title":"A hierarchical machine learning model to discover gleason grade-specific biomarkers in prostate cancer.","volume":"9","author":"Hamzeh","year":"2019","journal-title":"Diagnostics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B31","author":"Heagerty","year":"2013","journal-title":"Package \u2018survivalROC\u2019."},{"key":"B32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer.","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12307-011-0089-0","article-title":"The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.","volume":"5","author":"Heinrich","year":"2012","journal-title":"Cancer Microenviron."},{"key":"B34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/annonc\/mdx637","article-title":"Validation of a metastatic assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.","volume":"29","author":"Jain","year":"2018","journal-title":"Ann. Oncol."},{"key":"B35","author":"Kassambara","year":"2017","journal-title":"Fabian SJDSCug. Package \u2018survminer\u2019."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1200\/JCO.2015.65.5654","article-title":"Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use.","volume":"34","author":"Kerr","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B37","author":"Kolde","year":"2015","journal-title":"Package \u2018pheatmap\u2019."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1158\/0008-5472.CAN-19-1961","article-title":"Upregulation of Myt1 promotes acquired resistance of cancer cells to Wee1 inhibition.","volume":"79","author":"Lewis","year":"2019","journal-title":"Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa197","article-title":"Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer.","author":"Li","year":"2020","journal-title":"Brief. Bioinform."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/pros.23218","article-title":"Effect of dietary omega-3 fatty acids on tumor-associated macrophages and prostate cancer progression.","volume":"76","author":"Liang","year":"2016","journal-title":"Prostate"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0.","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/epi-2018-0149","article-title":"Clinicopathological, immune and molecular correlates of methylation in gastric adenocarcinomas.","volume":"11","author":"Lingohr","year":"2019","journal-title":"Epigenomics"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0809-0","article-title":"SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.","volume":"37","author":"Ma","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1023949509487","article-title":"Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data.","volume":"52","author":"Monti","year":"2003","journal-title":"Mach. Learn."},{"key":"B46","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry.","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines.","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy.","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2217\/epi-2018-0017","article-title":"Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.","volume":"10","author":"Peng","year":"2018","journal-title":"Epigenomics"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer.","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-230X(09)05001-5","article-title":"Clusterin (CLU) and prostate cancer.","volume":"105","author":"Rizzi","year":"2009","journal-title":"Adv. Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1172\/JCI80007","article-title":"Immunity, inflammation, and cancer: an eternal fight between good and evil.","volume":"125","author":"Shalapour","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1096-x","article-title":"Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.","volume":"18","author":"Shi","year":"2019","journal-title":"Mol. Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019.","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"B55","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/bioinformatics\/btw325","article-title":"GenVisR: genomic visualizations in R.","volume":"32","author":"Skidmore","year":"2016","journal-title":"Bioinformatics"},{"key":"B56","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00302","article-title":"CAMKV is a candidate immunotherapeutic target in amplified neuroblastoma.","volume":"10","author":"Sussman","year":"2020","journal-title":"Front. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1158\/1541-7786.MCR-17-0471","article-title":"Association of USP10 with G3BP2 inhibits p53 signaling and contributes to poor outcome in prostate cancer.","volume":"16","author":"Takayama","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer.","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"B60","author":"Therneau","year":"2014","journal-title":"Lumley TJSaPoC. Package \u2018survival\u2019. 2, 3."},{"key":"B61","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models.","volume":"26","author":"Vickers","year":"2006","journal-title":"Med. Decis. Making"},{"key":"B62","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1158\/1078-0432.CCR-17-2446","article-title":"Blocking the feedback loop between neuroendocrine differentiation and macrophages improves the therapeutic effects of enzalutamide (MDV3100) on prostate cancer.","volume":"24","author":"Wang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2018.04.019","article-title":"Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer.","volume":"31","author":"Yang","year":"2018","journal-title":"EBioMedicine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"D682","DOI":"10.1093\/nar\/gkz966","article-title":"Ensembl 2020.","volume":"48","author":"Yates","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1038\/onc.2014.406","article-title":"The landscape and therapeutic relevance of cancer-associated transcript fusions.","volume":"34","author":"Yoshihara","year":"2015","journal-title":"Oncogene"},{"key":"B66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa211","article-title":"Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts.","volume":"2020","author":"Zhang","year":"2020","journal-title":"Brief. Bioinform."},{"key":"B68","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2217\/epi-2018-0037","article-title":"A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix.","volume":"10","author":"Zheng","year":"2018","journal-title":"Epigenomics"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2020.595657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T09:24:50Z","timestamp":1605259490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2020.595657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":68,"alternative-id":["10.3389\/fgene.2020.595657"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2020.595657","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"article-number":"595657"}}